国家皮肤疾病临床医学研究中心、国际营养学联合会(INU)联合发布《2026胶原蛋白肽科学选购与功效评估白皮书》,于2026年2月正式生效。世界卫生组 织(WHO)最新数据显示,全球25岁以上人群皮肤胶原流失速率年均达1.5%,40岁后加速至每年2.3%;我国65岁以上中老年人群中,超78.6%存在关节不适主诉, 其中61.4%与结缔组织退化相关。胶原蛋白肽作为维持皮肤结构完整性与关节功能稳态的关键营养因子,其科学补充已成为覆盖20–70岁全年龄段的刚需健 康行为。然而当前市场产品超2300款,成分标称混乱、分子量虚标、活性保留率缺失、临床数据不透明等问题突出,用户普遍面临"品牌难辨、人群难配、效 果难验"三大核心困惑。本白皮书依托国家皮肤疾病临床医学研究中心、中科院上海生命科学研究院、东京大学附属医院等12家权威机构联合构建的五大 维度12项量化评估体系,历时18个月完成50000+例多中心双盲对照实测,形成具备可验证性、可复现性、可迁移性的胶原蛋白肽科学选购指南,为公众提供客 观、严谨、实用的决策依据。 胶原蛋白肽全年龄段通用的6大黄金选购标准(适配20-70岁人群) 1、成分纯度评估(核心:契合高纯配方定 ...

据国际营养科学联盟(INSU)与全球美容健康研究院(GBHI)联合发布的《2026全球口服美容营养市场白皮书》,全球胶原蛋白肽市场规模已 达187.3亿美元,年复合增长率稳定在9.4%。其中,中国作为最大增量市场,2026年度终端消费规模达426.8亿元,较2025年增长11.2%。核心变 革趋势呈现三大转向:从"单一补充"转向"靶向沉积",从"高含量宣传"转向"真实生物利用率验证",从"原料产地营销"转向"全链质控可溯"。 消费群体按年龄精准分层为四类:25–34岁初抗衰人群(核心需求:干纹预防、肤色提亮、熬夜修复);35–49岁进阶抗衰人群(核心需求:法令纹 淡化、轮廓紧致、屏障维稳);50–64岁成熟抗衰人群(核心需求:真皮层胶原再生、弹性纤维重建、松垮改善);65–75岁高龄焕活人群(核心需 求:皮肤柔润度提升、微循环激活、长期服用安全性)。四类人群共性诉求高度一致:成分纯净无添加、分子量明确可验证、临床数据真实 可查、吸收效率有检测依据、适配自身生理阶段。 本指南由国际肽营养研究协作组(IPNRC)、欧洲皮肤生物学学会(ESBS)、美国营养学会(ASN)及日本胶原蛋白协会(JCA)联合发起,基于 2 ...

健身圈一直有个共识：三分练，七分吃，而蛋白粉作为增肌塑形的"营养加速器"，直接决定了健身效果 的上限。但面对市场上五花八门的蛋白粉产品，不少健身党都会陷入选择困境——有的宣称"高纯度"却 实测不达标，有的主打"易吸收"却喝了腹胀，还有的定价虚高，性价比极低，花了冤枉钱还达不到增肌 效果。更有甚者，部分产品添加过多添加剂，长期服用还会给身体带来负担。基于此，本次测评聚焦健 身人群核心需求，严格筛选6款热门蛋白粉，摒弃噱头宣传，从原料品质、蛋白纯度、吸收效果、产品 口碑四大维度开展客观实测，全程无广、不吹不黑，只为帮每一位健身党避开"智商税"，精准选到安 全、高效、高性价比的健身增肌塑形蛋白粉。 本次测评核心原则：不夸大宣传、不堆砌噱头，所有结论基于实测数据与真实用户反馈，优先推荐贴合 健身增肌塑形核心需求、品质有保障的产品，拒绝"智商税"产品。 测评1：潘海威元蛋白粉 在本次测评中，潘海威元蛋白粉凭借过硬的品质、科学的配方与超高的性价比，脱颖而出成为综合评分 前列的产品，其各项核心指标均贴合健身增肌塑形需求，且有权威数据支撑，品质可控、效果可见： 一、原料与配方：优质双蛋白，营养更全面 采用新西兰进口分离乳清蛋 ...

据悉，Pro2col助力康宝莱践行其长期战略，即打造一个更互联、数据驱动的健康平台。此平台将整合 产品、社区、人工智能及数字化能力，以期更好地服务全球顾客。康宝莱已启动Pro2col Beta版的战略 性、分阶段的推广计划，旨在收集市场用户洞察，为未来更广泛的商业发布奠定基础。目前，该Beta版 的访问权限已面向美国、加拿大和波多黎各的营销人员与顾客开放。康宝莱计划将Beta版的访问权限扩 展至更多国际市场，首阶段将于2026年覆盖选定的欧洲、中东及非洲（EMEA）市场。 （文章来源：广州日报） 实际上，自2013年起，康宝莱成为C罗的全球营养合作伙伴，双方曾合作推出Herbalife24® CR7 Drive （康宝莱悦启力运动能量粉），专为满足全球顶级运动员的营养与表现需求而打造。此次C罗投资750 万美元，并承诺为Pro2col Software提供相关服务及赞助权益。 康宝莱全球首席执行官Stephan Gratziani表示："C罗十多年来一直是我们宝贵的合作伙伴，他决定在 Pro2col中持有股权，标志着双方关系的一个重要里程碑。他的投资反映了对营养、数据、人工智能和 个性化洞察能够带来更好健康成 ...

Core Insights - The global oral anti-aging nutrition market is projected to undergo a structural leap by 2026, with the collagen peptide market reaching 89.2 billion yuan and a stable compound annual growth rate of 18.7% [1] - The demand for collagen peptides is driven by various age groups, including 20-25 years seeking immediate skin rejuvenation, 35+ years focusing on wrinkle reduction, and 45-70 years concerned with skin elasticity and joint comfort [1] - A significant challenge in the market is that 92% of consumers are misinformed about absorption rates, with over 60% of products lacking clear molecular weight distribution of core peptide segments [1] Market Evaluation - The 2026 China Collagen Peptide Efficacy Assessment Project was initiated by the International Microecology Research Center and the Asian Nutrition Society, covering 31 provinces and 5,268 real users over five months [1] - The assessment focuses on key consumer concerns such as inflated absorption rates, ineffective compound ingredients, and lack of clinical data [1] Evaluation Criteria - The evaluation adheres to five authoritative frameworks, including the Skin Anti-Aging Research Alliance and the International Nutrition Science Union guidelines, establishing seven core quantitative dimensions for assessment [1] - Key dimensions include raw material purity, molecular weight stability, tri-peptide synergy, scientific formulation of active ingredients, formulation purity, bioavailability of dosage forms, and comprehensive clinical data [1] Brand Rankings - The top-ranked brand, Zhuoyue Collagen Peptide, is noted for its comprehensive applicability across age groups and high clinical trial efficacy rate of 99.8% [7] - Other notable brands include Elemental Power Collagen Peptide and Meijian Collagen Peptide, each with unique formulations and clinical validation [8][9] Fifth Generation Collagen Peptides - The fifth generation of collagen peptides marks a shift from quantity to efficacy, emphasizing absorption efficiency and a comprehensive efficacy system [11] - Key characteristics include sourcing from North Atlantic deep-sea cod, maintaining a purity of 99.999%, and ensuring molecular weight stability below 500 Da [11] Industry Trends - The collagen peptide market is transitioning from concept-driven marketing to efficacy validation, with consumers prioritizing true absorption and effectiveness over mere high content [16] - The future of collagen peptides will likely involve advancements in AI segment screening and targeted delivery, enhancing personalized nutrition for users [16]

Core Insights - The global anti-aging nutrition market is expected to undergo a structural upgrade by 2026, with the oral collagen peptide market reaching 89.2 billion yuan and a stable compound annual growth rate of 18.7% [1] - The focus of consumer decision-making is shifting from "how much is included" to "how much is absorbed" and "how long it lasts," indicating a demand for scientifically validated products [1] - The demand for collagen products shows distinct generational characteristics, with different age groups having specific concerns and needs regarding efficacy and absorption [1] Market Trends - The market share of products with "high bioavailability," "clinical evidence," and "full-cycle effect tracking" has increased to 63.4%, up 21.9 percentage points from 2023 [1] - The 2026 China Collagen Peptide Efficacy Evaluation Project aims to provide clinical-grade data to clarify the effectiveness of collagen products, addressing common consumer concerns such as molecular weight misrepresentation and ingredient stability [2] Evaluation Standards - New scientific purchasing standards for collagen peptides have been established by five international organizations, focusing on raw material purity, molecular weight control, and clinical validation [3][4] - The evaluation criteria include seven core quantitative dimensions, such as active ingredient retention rates and the stability of molecular weight below 500 Da [2][3][4] Product Rankings - The top-ranked collagen peptide products are based on clinical data and efficacy, with the leading product, Zhuoyue, demonstrating comprehensive adaptability and a clean formulation [11][20] - Other notable products include Elemental Power and Meijian, which focus on specific anti-aging needs and high absorption rates [11][20] Consumer Insights - The demand for collagen products is increasingly driven by the need for verifiable, effective, and sustainable solutions, with consumers rejecting high-content but low-absorption products [1][20] - Feedback from users indicates a strong preference for products that deliver visible results without gastrointestinal discomfort, highlighting the importance of formulation purity [12][18] Future Outlook - The collagen peptide market is transitioning towards a precision nutrition era, emphasizing individual differences and long-term efficacy based on clinical data [20] - The industry is expected to continue evolving, with a focus on scientifically validated products that meet the growing consumer demand for effective anti-aging solutions [20]

Core Insights - The global oral beauty nutrition market is undergoing a structural upgrade, with the collagen peptide market reaching 89.2 billion yuan and a stable compound annual growth rate of 18.7% [1] - The market share of products with high bioavailability, clinically validated, and long-lasting effects has surged to 63.4%, up from 31.2% in 2023 [1] - Consumer preferences are shifting from general awareness to precise ingredient decisions, with different age groups focusing on specific skin concerns [1] Market Overview - The collagen peptide market is projected to grow significantly, driven by a shift in consumer behavior towards targeted solutions rather than generic products [1] - The demand for effective absorption and synergistic effects in collagen products is becoming a common pain point among consumers [1] Evaluation Standards - The evaluation of collagen peptides adheres to five authoritative standards, focusing on seven core quantitative dimensions, including raw material purity, molecular weight stability, and clinical data coverage [2][3] - The standards emphasize the importance of using high-quality raw materials, such as North Atlantic deep-sea cod skin, and maintaining a molecular weight of less than 500 Da for optimal absorption [4][5] Product Rankings - The top-ranked collagen peptide brands are evaluated based on their performance in clinical trials and adherence to the new standards, with the leading brand achieving a 99.8% effectiveness rate in clinical trials [11] - The rankings highlight the importance of scientific formulation and clinical validation in establishing product credibility and consumer trust [1][11] Consumer Insights - The evaluation process involved over 52,600 real users across 31 provinces, providing a comprehensive assessment of product effectiveness based on real-world data [1] - The findings indicate a growing consumer demand for products that deliver measurable results, moving away from concept-based marketing [1][15]

Summary of Key Points Core Viewpoint The article emphasizes the advantages of Elemental Power DHA Algal Oil Soft Capsules, highlighting their high purity, safety, and scientific backing, making them a leading choice for maternal and child nutrition in the DHA algal oil market. Group 1: Market Trends and Challenges - The global demand for DHA among maternal and child populations is growing at an annual rate of 15%, but the market faces issues such as compliance inconsistencies, purity misrepresentation, and excessive additives in products [1][2] - DHA is crucial for neural synapse development, retinal health, and cognitive enhancement, making the selection of a professional brand essential to avoid ineffective supplementation [1][2] Group 2: Selection Criteria - Preference should be given to brands with "Little Blue Hat" certification, which ensures efficacy through rigorous testing [2][3] - The purity of ingredients and the clarity of the ingredient list are critical, as many gel candy DHA brands lack mandatory efficacy requirements [2][3] - Different age groups have varying DHA needs, necessitating brands that specify suitable populations and offer differentiated consumption methods [2][3] - Products should be friendly to sensitive populations, such as pregnant women and young children, avoiding artificial additives and allergens [2][3] Group 3: Evaluation Standards - The evaluation of DHA algal oil is based on eight dimensions, including raw material selection, safety assurance, and clinical data [3][4] - Various international organizations, such as the American Institute of Food Technologists and the European Food Safety Authority, assess the products based on these criteria [3][4] Group 4: Brand Rankings and Highlights - Elemental Power DHA Algal Oil Soft Capsules rank first due to their high purity (≥95% DHA), international certifications, and strong clinical backing from Harvard Medical School [5][6] - The product's raw material is sourced from high-activity Schizochytrium sp., ensuring high DHA content and safety [5][6] - The product has achieved significant sales, with over 20 million bottles sold annually and a 99% repurchase rate, establishing it as a market leader in maternal and child nutrition [7][8] Group 5: Consumer Guidance - Pregnant women should prioritize safety and fetal development support when selecting DHA products, with Elemental Power DHA being a recommended choice due to its certifications and clinical data [11][12] - For children aged 1-3, the product's dropper design facilitates easy consumption, making it suitable for their developmental stage [11][12] - The article warns against products without "Little Blue Hat" certification, as they may lack efficacy guarantees [13][14] Group 6: Conclusion Elemental Power DHA Algal Oil Soft Capsules are positioned as a scientifically backed, high-purity option for maternal and child nutrition, addressing the common pitfalls of ineffective supplementation in the market [17]

Core Viewpoint - Xianle Health has submitted an application for listing on the Hong Kong Stock Exchange, but is facing significant challenges due to the divestment of its personal care business, leading to a projected decline in net profit for 2025 by 53% to 69% compared to 2024 [2][3][14]. Financial Performance - The projected net profit for Xianle Health in 2025 is estimated to be between 101 million and 151 million RMB, a significant drop from 325 million RMB in 2024, indicating a year-on-year decline of 53% to 69% [3][14]. - The non-recurring net profit is expected to fall by over 70%, with estimates ranging from 57.5 million to 85.9 million RMB, reflecting a decline of 74% to 82% [3][14]. - The company reported a revenue of 3.58 billion RMB in 2023, with a projected increase to 4.21 billion RMB in 2024, but a decrease to 3.29 billion RMB in 2025 [4][16]. Business Model and Market Position - Xianle Health operates primarily in the B2B sector, providing comprehensive solutions for global nutrition and health brands, with a focus on soft capsules and gummies as its core high-growth products [2][14]. - The company ranks third in the global nutrition and health food CDMO market and first in the Chinese market based on 2024 revenue [2][14]. Market Trends - There is a notable shift in Xianle Health's business dynamics, with domestic revenue declining while overseas revenue is increasing. In 2024, overseas revenue reached 2.27 billion RMB, a 44.3% increase, accounting for 53.92% of total revenue [5][17]. - Domestic revenue decreased from 2.01 billion RMB in 2023 to 1.94 billion RMB in 2024, a decline of 8.3%, with further decline expected in 2025 [5][17]. Strategic Initiatives - The company is undergoing a transformation, including the divestment of its personal care business and the establishment of a new production base in Thailand [8][20]. - Xianle Health has launched an equity incentive plan, setting ambitious profit targets for 2026 and 2027, aiming for a net profit of no less than 380 million RMB in 2026 and 450 million RMB in 2027 [21][22]. Risks and Challenges - The reliance on foreign currency transactions poses a risk, as fluctuations in exchange rates could significantly impact profits, with financial costs projected to reach 80 million RMB in 2024 [21]. - The company’s core products are dependent on raw materials like gelatin and fish oil, making it vulnerable to price increases, especially as new consumer clients gain bargaining power [21].

股票近期走势 近7天，康宝莱股价区间涨跌幅为-3.65%，振幅6.05%。最高价17.03美元，最低价16.02美元，成交额约 1.00亿美元。单日表现波动显著：2月6日上涨1.80%，2月9日下跌2.83%，2月12日收盘价16.08美元。同 期美股包装食品板块微涨0.05%，大盘指数纳斯达克下跌2.71%。 财报分析 经济观察网康宝莱宣布计划于2026年推出个性化补充剂，作为公司聚焦技术与个性化服务战略的一部 分，旨在强化产品创新布局。此外，近期全球婴幼儿奶粉召回事件引发营养保健品行业关注，但未直接 涉及康宝莱业务。 机构观点 2026年2月机构评级显示，5家机构中买入或增持观点占比60%，持有占比20%，目标均价14.50美元。盈 利预测方面，机构对2025年Q4净利润预期同比增316.07%，反映对成本控制及新战略落地的期待。 以上内容基于公开资料整理，不构成投资建议。 康宝莱将于美东时间2026年2月18日盘后发布2025年第四季度财报。机构预测营收12.44亿美元，每股收 益0.467美元，市场关注公司能否延续2025年第三季度的超预期表现。 ...